Article -> Article Details
| Title | Fetal macrosomia market Trends in the Industry Global Analysis by Key Players to 2023 |
|---|---|
| Category | Fitness Health --> Men's Health |
| Meta Keywords | Fetal macrosomia market |
| Owner | vinit |
| Description | |
| Market Highlights The global fetal
macrosomia market has been evaluated as a steady market and it is
expected to continue growing in the near future. Increasing incidence of fetal
macrosomia is the major driver for this market. Introduction and increasing
adoption of advanced diagnostic tools for effective diagnostic and treatment
management is another important factor for the market growth. Companies are investing
in development of new and innovative device development is also key driver for
the market growth. The market for fetal macrosomia was around USD 2290.2
million in 2016 and is expected to reach USD 3034.1 million by 2023 which is a
projected CAGR of 4.1%. Major players in fetal macrosomia market There are plenty of large and small market players which
operate in this market: Carestream Health (US), Esaote SpA (Italy),
Fonar Corporation (US), Fujifilm Holdings Corporation (Japan), GE
Healthcare (UK), Hitachi Medical Corporation (Japan), Hologic, Inc.
(US), Philips Healthcare (Netherlands), Samsung Medison Co. Ltd
(Republic of Korea), Shimadzu Corporation (Japan), Siemens
Healthcare (Germany), Toshiba Corporation (Japan),) and others. Regional Analysis: Considering the global scenario of the fetal macrosomia market, there are four main regions, America, Europe, Asia Pacific, and Middle East & Africa.
America is the largest market for fetal macrosomia. The Americas mainly include
North America and South America. North America is holding the largest market
share in which US is dominating this market. Some major factors like advanced
diagnostic and treatment facilities, rapid adoption of healthcare practices,
and increasing investment in research are the driving forces for the growth for
North America fetal macrosomia market. European region is the second important
market, especially West European countries are dominating this region. Eastern
European countries are also showing significant growth in this market. Asia
Pacific market is witnessing rapid growth due to increasing awareness of the
diseases, increasing spending and government initiative to increase awareness
as well as to provide affordable healthcare. Talking about the market scenario
of Middle East & Africa, this region is expected to grow slower than
the global average due to various inhibiting factors such as lack of knowledge,
limited access to the required healthcare facilities, traditional healthcare
facilities etc. Segmentation: Global fetal macrosomia market has been segmented on the
basis of diagnosis which comprise of ultrasound, antenatal testing, and others.
Ultrasound is further sub-segmented into standard ultrasound, transvaginal
scan, fetal echocardiography, 3-d ultrasound, dynamic 3-d ultrasound, and
others. Antenatal testing is further sub-segmented into blood and urine tests,
amniocentesis, chorionic villus sampling, and others. On the basis of treatments, the market has been segmented
into medical care, surgical care, and others. Surgical Care is sub-segmented
into cesarean delivery, and others. On the basis of end user, it is segmented into hospital and
clinics, medical research centers, academic institutes, and others. About Market Research Future: MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with technology and work process of
the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members. | |